Cargando…

HAS2-Ezrin-ER axis plays a role in acquired antiestrogen resistance of ER-positive breast cancer

The development of endocrine resistance is a major clinical problem in estrogen receptor-positive (ER(+)) breast cancer (BrCa) treatment, in which how cancer cells acquire resistance remains obscure. Hyaluronan synthase 2 (HAS2) is the most critical synthase in producing hyaluronan and is well known...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xiaodan, Tang, Fen, Guo, Qian, Liu, Yiwen, He, Yiqing, Du, Yan, Gao, Feng, Zhang, Guoliang, Yang, Cuixia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659586/ https://www.ncbi.nlm.nih.gov/pubmed/36386154 http://dx.doi.org/10.3389/fphar.2022.1031487

Ejemplares similares

G0S2 promotes antiestrogenic and pro-migratory responses in ER+ and ER- breast cancer cells
por: Corbet, Andrea K., et al.
Publicado: (2023)

ZEB1 induces ER-α promoter hypermethylation and confers antiestrogen resistance in breast cancer
por: Zhang, Jianbo, et al.
Publicado: (2017)

Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER(+) Breast Cancer
por: Servetto, Alberto, et al.
Publicado: (2021)

Fulvestrant as a reference antiestrogen and estrogen receptor (ER) degrader in preclinical studies: treatment dosage, efficacy, and implications on development of new ER-targeting agents
por: Wang, Guangdi
Publicado: (2020)

Estrogen Receptor-Alpha 36 Mediates Mitogenic Antiestrogen Signaling in ER-Negative Breast Cancer Cells
por: Zhang, XinTian, et al.
Publicado: (2012)

Has Hawking erred?
por: Kraus, G
Publicado: (1993)

Upregulation of the EGFR/MEK1/MAPK1/2 signaling axis as a mechanism of resistance to antiestrogen-induced BimEL dependent apoptosis in ER(+) breast cancer cells
por: Hagan, Mackenzie L., et al.
Publicado: (2022)

CD44/HA signaling mediates acquired resistance to a PI3Kα inhibitor
por: Yang, Cuixia, et al.
Publicado: (2020)

Cryptotanshinone Is a Intervention for ER-Positive Breast Cancer: An Integrated Approach to the Study of Natural Product Intervention Mechanisms
por: Li, Huayao, et al.
Publicado: (2021)

Apigenin Attenuates the Allergic Reactions by Competitively Binding to ER With Estradiol
por: Yao, Lu, et al.
Publicado: (2020)

Inhibition of histone methyltransferase DOT1L silences ERα gene and blocks proliferation of antiestrogen-resistant breast cancer cells
por: Nassa, Giovanni, et al.
Publicado: (2019)

Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family
Publicado: (1994)

Interventional Efects of the Topical of “Sanse Powder” Essential Oils Nanoemulsion on Knee Osteoarthritis in Rats by Targeting the ERS/TXNIP/NLRP3 Signaling Axis
por: Liu, Zixiu, et al.
Publicado: (2021)

YAP inhibits ERα and ER(+) breast cancer growth by disrupting a TEAD-ERα signaling axis
por: Li, Xu, et al.
Publicado: (2022)

The ZNF217 Biomarker Predicts Low- and High-Risk Oncotype DX(®) Recurrence Score in ER-Positive Invasive Breast Cancers
por: Cohen, Pascale A., et al.
Publicado: (2019)

Activation of CD44 signaling in leader cells induced by tumor-associated macrophages drives collective detachment in luminal breast carcinomas
por: Gao, Feng, et al.
Publicado: (2022)

Expression of oestrogen receptors, ERα, ERβ, and ERβ variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERα
por: Collins, Frances, et al.
Publicado: (2009)

The pitfall of the transient, inconsistent anticancer capacity of antiestrogens and the mechanism of apparent antiestrogen resistance
por: Suba, Zsuzsanna
Publicado: (2015)

β2-microglobulin has a different regulatory molecular mechanism between ER(+) and ER(−) breast cancer with HER2(−)
por: Chai, Dandan, et al.
Publicado: (2019)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Andrographolide Inhibits ER-Positive Breast Cancer Growth and Enhances Fulvestrant Efficacy via ROS-FOXM1-ER-α Axis
por: Xu, Tong, et al.
Publicado: (2022)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (−) Breast Cancer
por: Du, Feng, et al.
Publicado: (2022)

The therapeutic potential of antioxidants, ER chaperones, NO and H(2)S donors, and statins for treatment of preeclampsia
por: Cindrova-Davies, Tereza
Publicado: (2014)

Chemical characterization and metabolic profiling of Xiao-Er-An-Shen Decoction by UPLC-QTOF/MS
por: Yang, Ruipei, et al.
Publicado: (2023)

Inflammatory Immune Cytokine TNF-α Modulates Ezrin Protein Activation via FAK/RhoA Signaling Pathway in PMVECs Hyperpermeability
por: Zhou, Qun, et al.
Publicado: (2021)

Super-enhancer-controlled positive feedback loop BRD4/ERα–RET–ERα promotes ERα-positive breast cancer
por: Zheng, Zao-zao, et al.
Publicado: (2022)

CD44 activation state regulated by the CD44v10 isoform determines breast cancer proliferation
por: Guo, Qian, et al.
Publicado: (2021)

Modulation of endothelial cell migration by ER stress and insulin resistance: a role during maternal obesity?
por: Sáez, Pablo J., et al.
Publicado: (2014)

Xiaoaiping Induces Developmental Toxicity in Zebrafish Embryos Through Activation of ER Stress, Apoptosis and the Wnt Pathway
por: Li, Juanjuan, et al.
Publicado: (2018)

Peroxisome Proliferator-Activated Receptor-Gamma Reduces ER Stress and Inflammation via Targeting NGBR Expression
por: Ma, Jialing, et al.
Publicado: (2022)

Xin-Ji-Er-Kang protects heart from ischemia-reperfusion injury by rebalancing lipid metabolism
por: Sun, Li-Jun, et al.
Publicado: (2022)

An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer
por: Zhou, Xin, et al.
Publicado: (2014)

PACS2–TRPV1 axis is required for ER–mitochondrial tethering during ER stress and lung fibrosis
por: Knoell, Jessica, et al.
Publicado: (2022)

Response of Estrogen Receptor-Positive Breast Cancer Tumorspheres to Antiestrogen Treatments
por: Ao, Ada, et al.
Publicado: (2011)

ER remodeling via ER-phagy
por: Gubas, Andrea, et al.
Publicado: (2022)

Fibroblast Growth Factor 22 Inhibits ER Stress-Induced Apoptosis and Improves Recovery of Spinal Cord Injury
por: Zhu, Sipin, et al.
Publicado: (2020)

Inhibition of ASIC1a-Mediated ERS Improves the Activation of HSCs and Copper Transport Under Copper Load
por: Kong, Lingjin, et al.
Publicado: (2021)

ER/AR Multi-Conformational Docking Server: A Tool for Discovering and Studying Estrogen and Androgen Receptor Modulators
por: Wang, Feng, et al.
Publicado: (2022)

Myricetin activates the Caspase-3/GSDME pathway via ER stress induction of pyroptosis in lung cancer cells
por: Han, Jicheng, et al.
Publicado: (2022)

Reduced hyaluronan cross-linking induces breast cancer malignancy in a CAF-dependent manner
por: Zhang, Guoliang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m73ga38kqe8ve4h342l54p67lb